1-3 of 3
Valeria A. De Melo
Close
Sort by
Journal Articles

EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors

Brief Report
Mustafa Daghistani, David Marin, Jamshid Sorouri Khorashad, Lihui Wang, Philippa C. May, Christos Paliompeis, Dragana Milojkovic, Valeria A. De Melo, Gareth Gerrard, John M. Goldman, Jane F. Apperley, Richard E. Clark, Letizia Foroni, Alistair G. Reid
Journal: Blood
Blood (2010) 116 (26): 6014–6017.
https://doi.org/10.1182/blood-2010-01-264234
Published: 2010
Includes: Supplemental data
Journal Articles

Common Submicroscopic Genomic Imbalances Accompany the Ph Chromosome at Diagnosis in Chronic Myeloid Leukemia

Jamshid S Khorashad, MD, Valeria A De Melo, Heike Fiegler, PhD, Gareth Gerrard, PhD, Dan Brudzevsky, PhD, David Marin, MD, Jane F. Apperley, MBChB, FRCP, FRCPath, John M Goldman, DM, FRCP, FRCPath, Letizia Foroni, MD, PhD, FRCPath, Alistair G Reid, PhD
Journal: Blood
Blood (2008) 112 (11): 3113.
https://doi.org/10.1182/blood.V112.11.3113.3113
Published: 2008
Journal Articles

Deletions Adjacent to BCR and ABL Breakpoints Occur in a Substantial Minority of Chronic Myeloid Leukaemia Patients with Masked Philadelphia Rearrangements.

Valeria A. De Melo, Paul Kotzampaltiris, Elisabeth Nacheva, MD, PhD, David Marin, MD, Jane F. Apperley, MD, PhD, Alistair G. Reid, PhD
Journal: Blood
Blood (2007) 110 (11): 2929.
https://doi.org/10.1182/blood.V110.11.2929.2929
Published: 2007